Riociguat is a soluble guanylate cyclase stimulator approved for pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). The objective of this study was to evaluate the change of right heart size and function assessed by echocardiography during long-term treatment with riociguat.

Change of right heart size and function by long-term therapy with riociguat in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension / Marra, ALBERTO MARIA; Egenlauf, Benjamin; Ehlken, Nicola; Fischer, Christine; Eichstaedt, Christina; Nagel, Christian; Bossone, Eduardo; Cittadini, Antonio; Halank, Michael; Gall, Henning; Olsson, Karen M; Lange, Tobias J; Grünig, Ekkehard. - In: INTERNATIONAL JOURNAL OF CARDIOLOGY. - ISSN 0167-5273. - 195:(2015), pp. 19-26-26. [10.1016/j.ijcard.2015.05.105]

Change of right heart size and function by long-term therapy with riociguat in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

MARRA, ALBERTO MARIA;
2015

Abstract

Riociguat is a soluble guanylate cyclase stimulator approved for pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). The objective of this study was to evaluate the change of right heart size and function assessed by echocardiography during long-term treatment with riociguat.
2015
Chronic thromboembolic pulmonary hypertension; Pulmonary arterial hypertension; Right atrium; Right ventricle; Riociguat; Adult; Aged; Atrial Function, Right; Chronic Disease; Echocardiography; Exercise Test; Female; Guanylate Cyclase; Heart Atria; Heart Ventricles; Humans; Hypertension, Pulmonary; Male; Middle Aged; Pulmonary Embolism; Pyrazoles; Pyrimidines; Treatment Outcome; Ventricular Function, Right; Walking
01 Pubblicazione su rivista::01a Articolo in rivista
Change of right heart size and function by long-term therapy with riociguat in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension / Marra, ALBERTO MARIA; Egenlauf, Benjamin; Ehlken, Nicola; Fischer, Christine; Eichstaedt, Christina; Nagel, Christian; Bossone, Eduardo; Cittadini, Antonio; Halank, Michael; Gall, Henning; Olsson, Karen M; Lange, Tobias J; Grünig, Ekkehard. - In: INTERNATIONAL JOURNAL OF CARDIOLOGY. - ISSN 0167-5273. - 195:(2015), pp. 19-26-26. [10.1016/j.ijcard.2015.05.105]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/964998
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 44
  • ???jsp.display-item.citation.isi??? 41
social impact